INVO
Price:
$0.833
Market Cap:
$3.25M
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.[Read more]
Industry
Medical - Devices
IPO Date
2020-11-02
Stock Exchange
NASDAQ
Ticker
INVO
According to INVO Bioscience, Inc.’s latest financial reports and current stock price. The company's current ROE is -1073.76%. This represents a change of -73.88% compared to the average of -4111.10% of the last 4 quarters.
The mean historical ROE of INVO Bioscience, Inc. over the last ten years is 38.10%. The current -1073.76% ROE has changed -2918.19% with respect to the historical average. Over the past ten years (40 quarters), INVO's ROE was at its highest in in the December 2022 quarter at 283.04%. The ROE was at its lowest in in the March 2024 quarter at -15721.45%.
Average
38.10%
Median
42.87%
Minimum
-899.91%
Maximum
1.11%
Discovering the peaks and valleys of INVO Bioscience, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 702.79%
Maximum Annual ROE = 1.11%
Minimum Annual Increase = -1323.98%
Minimum Annual ROE = -899.91%
Year | ROE | Change |
---|---|---|
2023 | -899.91% | -180.77% |
2022 | 1.11% | -1323.98% |
2021 | -91.03% | -37.37% |
2020 | -145.34% | -349.02% |
2019 | 58.37% | -48.31% |
2018 | 112.92% | 702.79% |
2017 | 14.07% | -69.42% |
2016 | 46.00% | -65.15% |
2015 | 132.00% | 232.12% |
2014 | 39.74% | 99.32% |
The current ROE of INVO Bioscience, Inc. (INVO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
41.09%
5-year avg
7.26%
10-year avg
38.10%
INVO Bioscience, Inc.’s ROE is greater than Entera Bio Ltd. (-36.64%), less than NLS Pharmaceutics AG (22.54%), greater than Enveric Biosciences, Inc. (-201.01%), greater than Lixte Biotechnology Holdings, Inc. (-149.08%), less than CLPS Incorporation (-4.05%),
Company | ROE | Market cap |
---|---|---|
-36.64% | $58.56M | |
22.54% | $8.48M | |
-201.01% | $3.31M | |
-149.08% | $3.67M | |
-4.05% | $30.90M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like INVO Bioscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like INVO Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is INVO Bioscience, Inc.'s ROE?
How is the ROE calculated for INVO Bioscience, Inc. (INVO)?
What is the highest ROE for INVO Bioscience, Inc. (INVO)?
What is the 3-year average ROE for INVO Bioscience, Inc. (INVO)?
What is the 5-year average ROE for INVO Bioscience, Inc. (INVO)?
How does the current ROE for INVO Bioscience, Inc. (INVO) compare to its historical average?